Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 81469-492

This document is a table showing the percentage reduction in CPS rate for Divalproex sodium compared to Placebo. It also indicates the percentage of patients who experienced improvement, no change, or worsening.*

This text provides information on the percentage reduction in the CPS rate for high dose and low dose treatment groups. It also indicates the percentage of patients showing improvement, no change, or worsening in their condition.*

This text contains information about Divalproex Sodium Delayed-Release Capsules, USP. The medication should be dispensed with a Medication Guide provided separately to each patient, and caution should be taken not to accept a seal-over bottle if the opening is broken or missing. The capsules are identified by their blue to bluish-transparent cap and off-white to white opaque body, with LS printed on the cap and 447 on the body. The storage temperature should be maintained between 5°C and 25°C. The product is manufactured for First Nation Group, LLC and is a product of Taiwan. The QR code can be scanned for medication information. The capsules can be swallowed whole or opened with contents placed on food for administration. The package insert should be referred to for complete prescribing information, and medications should be kept out of reach of children.*

This text provides details about Divalproex Sodium Delayed-Release Capsules, including dosage instructions, storage guidelines, and manufacturer information. It emphasizes the importance of dispensing the medication guide to each patient and keeping medication out of reach of children. The text also includes a code number for identification and a web link to access the medication guide online.*